background
respiratori
viral
infect
character
infiltr
leukocyt
includ
activ
neutrophil
lung
lead
sustain
lung
injuri
potenti
contribut
chronic
lung
diseas
specif
mechan
recruit
neutrophil
lung
virusinduc
lung
inflamm
injuri
fulli
elucid
sinc
act
potent
neutrophil
chemoattract
investig
role
dsrnainduc
lung
injuri
dsrna
poli
ic
welldescrib
synthet
agent
mimick
acut
viral
infect
use
week
old
femal
balbc
mice
intratrach
inject
either
singlestrand
ssrna
doublestrand
rna
dsrna
airway
lung
harvest
design
timepoint
character
elicit
chemokin
respons
result
lung
injuri
follow
dsrna
exposur
demonstr
qualitit
histopatholog
analysi
quantit
fac
protein
mrna
analysi
bal
fluid
tissu
sampl
repeat
experi
first
pretreat
mice
antipmn
correspond
control
antibodi
subsequ
pretreat
separ
cohort
mice
correspond
control
antibodi
prior
dsrna
exposur
intratrach
dsrna
led
signific
increas
neutrophil
infiltr
lung
injuri
balb
c
mice
h
follow
dsrna
respons
ssrna
poli
c
control
treatment
express
ligand
parallel
neutrophil
recruit
lung
neutrophil
deplet
studi
significantli
reduc
neutrophil
infiltr
lung
injuri
respons
dsrna
mice
pretreat
antipmn
monoclon
ab
furthermor
inhibit
interact
pretreat
dsrnaexpos
mice
neutral
ab
also
significantli
attenu
neutrophil
sequestr
lung
injuri
conclus
find
demonstr
cxc
chemokin
biolog
axi
critic
pathogenesi
dsrnainduc
lung
injuri
relev
acut
viral
infect
viral
infect
respiratori
tract
caus
common
cold
flu
children
adult
infect
may
predispos
certain
patient
develop
chronic
respiratori
disord
asthma
chronic
obstruct
pulmonari
diseas
copd
pulmonari
fibrosi
bronchopulmonari
dysplasia
bpd
clinic
symptom
includ
mucu
secret
alter
airway
reactiv
hallmark
recruit
inflammatori
cell
result
chang
airway
epitheli
cell
line
inflamm
also
extend
lung
caus
parenchym
diseas
characterist
viral
pneumonia
observ
recent
sever
acut
respiratori
syndrom
sar
inflammatori
cell
recruit
larg
part
elicit
gener
chemokin
chemotact
cytokin
also
import
establish
proinflammatori
environ
underli
chronic
respiratori
disord
asthma
copd
cystic
fibrosi
pulmonari
fibrosi
bpd
inflammatori
chang
due
viral
infect
result
host
immun
respons
rather
secondari
viral
replic
viral
particl
viral
infect
epitheli
cell
character
gener
proinflammatori
molecul
doublestrand
rna
dsrna
intracellular
replic
virus
studi
human
epitheli
cell
line
vitro
dsrna
trigger
innat
immun
respons
host
cell
via
gener
cytokin
chemokin
involv
inflammatori
cell
recruit
specif
dsrna
shown
induc
activ
neutrophil
chemoattract
regul
activ
normal
cell
express
secret
rant
human
subject
vivo
elev
tracheal
level
neutrophil
accumul
found
airway
patient
asthma
copd
viral
infect
anim
model
vivo
larg
studi
system
effect
intraperiton
dsrna
treatment
pauciti
inform
character
role
chemokin
lung
inflamm
injuri
follow
intratrach
dsrna
instil
murin
glutam
acidleucinearginineposit
elrposit
cxc
chemokin
structur
homolog
human
respect
function
homolog
human
cxc
chemokin
murin
chemokin
share
abil
signal
g
proteincoupl
receptor
human
structur
function
homolog
associ
asthma
copd
viral
infect
lung
current
studi
hypothes
earli
inflamm
result
lung
injuri
intratrach
dsrna
treatment
due
part
express
elrposit
cxc
chemokin
interact
major
receptor
test
hypothesi
inject
dsrna
intratrach
week
old
femal
balbc
mice
measur
neutrophil
chemokin
respons
result
injuri
airway
lung
tissu
compart
block
respons
pretreat
anim
antibodi
specif
neutral
neutrophil
recruit
chemokinedepend
manner
therebi
decreas
lung
inflamm
injuri
anim
model
demonstr
critic
role
acut
lung
inflamm
injuri
due
intratrach
dsrna
rna
instil
doublestrand
rna
dsrna
poli
ic
singlestrand
rna
ssrna
poli
c
purchas
sigmaaldrich
corp
st
loui
mo
reconstitut
steril
normal
salin
store
prior
use
captur
detect
antibodi
murin
murin
purchas
duoset
r
system
minneapoli
mn
neutral
studi
purifi
rat
antimous
mab
clone
purchas
bd
pharmingen
san
diego
ca
use
neutrophil
deplet
studi
previous
describ
polyclon
goat
antimurin
produc
immun
goat
peptid
contain
ligandbind
sequenc
metglygluphelysvalasplyspheasnilegluaspphephesergli
goat
immun
multipl
intraderm
site
complet
freund
adjuv
cfa
follow
least
boost
incomplet
freund
adjuv
ifa
previous
describ
direct
elisa
use
evalu
antisera
titer
sera
use
western
blot
elisa
neutral
assay
titer
reach
greater
protein
sequenc
shown
contain
ligandbind
portion
receptor
antibodi
use
previous
block
mous
vivo
shown
detect
western
blot
fluorescenceactiv
cell
sort
analysi
neutrophil
vivo
antibodi
shown
neutral
use
vitro
neutrophil
chemotaxi
assay
vivo
abrog
influx
neutrophil
peritoneum
normal
mice
respons
exogen
elrposit
murin
cxc
chemokin
vivo
administr
antibodi
inhibit
pulmonari
neutrophil
sequestr
murin
model
aspergillosi
nocardia
pseudomona
pneumonia
prevent
influx
neutrophil
urin
kidney
murin
model
escherichia
coli
urinari
tract
infect
moreov
intraperiton
administr
antibodi
alter
peripher
blood
neutrophil
count
ml
antiserum
control
antibodi
approxim
mg
igg
use
week
old
femal
balbc
mice
intratrach
inject
either
singlestrand
ssrna
doublestrand
rna
dsrna
use
modif
previous
describ
method
mice
anesthet
ketamin
mgkg
intraperiton
steril
condit
anterior
neck
soft
tissu
dissect
expos
trachea
rna
mous
wt
inject
via
gaug
tuberculin
needl
syring
attach
stepper
microinjector
indicon
inc
brookfield
ct
trachea
direct
visual
immedi
follow
instil
skin
appos
close
use
tissu
adhes
mice
allow
recov
anesthesia
prior
replac
cage
separ
experi
anim
receiv
either
ml
goat
polyclon
antimurin
ml
normal
goat
serum
ng
control
antibodi
ml
rat
antimous
mab
correspond
control
intraperiton
hour
intratrach
inject
daili
time
sacrific
previous
describ
time
sacrific
h
follow
intratrach
dsrna
ssrna
treatment
mice
euthan
use
intraperiton
pentobarbit
mgkg
heparin
sampl
blood
harvest
thorac
caviti
expos
lung
perfus
free
blood
ml
normal
salin
via
spontan
beat
right
ventricl
constant
pressur
cm
h
gaug
butterfli
needl
use
cannul
trachea
bronchoalveolar
lavag
bal
perform
instil
ml
pb
mm
edta
solut
previous
describ
lung
lavag
constant
pressur
cm
h
retriev
solut
centrifug
g
min
cellfre
supernat
assay
specif
elisa
collect
cell
analyz
total
cell
count
cytospin
differenti
lung
tissu
process
follow
calcul
lung
edema
microvascular
permeabl
mrna
elisa
analysi
histopatholog
immunohistochem
analysi
fix
paraformaldehyd
cm
pressur
embed
paraffin
paraffinembed
tissu
dsrnatreat
ssrnatreat
lung
process
immunohistochem
local
tolllik
receptor
express
use
method
previous
describ
briefli
tissu
section
dewax
xylen
rehydr
grade
concentr
ethanol
tissu
nonspecif
bind
site
block
use
power
block
biogenex
san
ramon
ca
tissu
section
overlaid
dilut
either
control
goat
polyclon
goat
antibodi
santa
cruz
biotechnolog
inc
santa
cruz
ca
tissu
section
wash
trisbuff
salin
incub
min
secondari
biotinyl
antibodi
tissu
section
wash
trisbuff
salin
incub
alkalin
phosphatas
conjug
streptavidin
biogenex
tissu
section
incub
vectastain
abc
reagent
vector
laboratori
burlingam
ca
follow
peroxidas
substrat
dab
reagent
vector
laboratori
optim
color
develop
tissu
section
immers
steril
water
counterstain
lerner
hematoxyin
cover
slip
use
aqueou
mount
solut
total
cellular
rna
lung
tissu
isol
previou
describ
total
rna
determin
ug
total
rna
revers
transcrib
cdna
amplifi
use
taqman
gene
express
quantif
assay
appli
biosystem
foster
citi
ca
kit
cdna
amplifi
quantifi
use
taqman
sequenc
detect
system
specif
primer
murin
murin
murin
housekeep
primer
use
sens
antisens
bp
sens
antisens
murin
bp
predevelop
assay
reagent
appli
biosystem
kit
use
murin
housekeep
gene
quantit
analysi
gene
express
done
use
compar
c
method
c
threshold
cycl
number
minimum
number
cycl
need
product
detect
arithmet
formula
method
differ
threshold
cycl
target
ie
endogen
refer
ie
housekeep
gene
amount
target
normal
endogen
refer
ie
dsrnatreat
anim
rel
calibr
normal
endogen
refer
ie
ssrnatreat
control
given
follow
exampl
compar
express
dsrnatreat
anim
ssrnatreat
control
dsrnatreat
ssrnatreat
control
normal
express
dsrnatreat
anim
normal
endogen
express
ssrnatreat
control
normal
endogen
calcul
give
rel
valu
compar
target
calibr
design
context
fold
increas
dsrnatreat
anim
ssrnatreat
control
target
mrna
rel
quantif
microvascular
permeabl
relat
lung
injuri
measur
use
modif
evan
blue
dye
extravas
techniqu
previous
describ
extravas
evan
blue
sigmaaldrich
extravascular
compart
use
quantit
measur
lung
injuri
chang
microvasculatur
permeabl
briefli
anim
receiv
mgkg
evan
blue
ph
tail
vein
inject
h
sacrific
time
sacrific
heparin
sampl
blood
harvest
plasma
remov
centrifug
six
lung
group
perfus
free
blood
ml
normal
salin
via
spontan
beat
right
ventricl
remov
thorac
caviti
trachea
mainstem
bronchi
surround
mediastin
structur
remov
evan
blue
extract
pulmonari
tissu
homogen
ml
normal
salin
volum
ad
vol
deioniz
formamid
incub
h
supernat
separ
centrifug
g
min
evan
blue
plasma
lung
tissu
quantit
dualwavelength
spectrophotometr
analysi
nm
method
correct
specimen
absorb
nm
absorb
contamin
heme
pigment
use
follow
formula
correct
absorb
nm
actual
absorb
nm
absorb
calcul
permeabl
index
divid
correct
pulmonari
plasma
evan
blue
absorb
nm
index
reflect
degre
extravas
evan
blue
extravascular
pulmonari
tissu
compart
quantit
lung
edema
follow
dsrna
treatment
wet
dri
weight
ratio
obtain
ligat
lung
away
hilum
previous
describ
lung
blot
dri
weigh
desicc
incub
overnight
vacuum
oven
reweigh
determin
dri
weight
wet
dri
ratio
calcul
protein
quantit
use
modif
doubl
ligand
method
previous
describ
briefli
flatbottom
well
microtit
plate
nunc
immunopl
coat
captur
antibodi
murin
kc
ugml
steril
phosphat
buffer
salin
pb
hr
room
temperatur
wash
phosphat
buffer
salin
pb
ph
wash
buffer
microtit
plate
nonspecif
bind
site
block
bsa
pb
incub
minut
plate
wash
three
time
wash
buffer
sampl
standard
ad
follow
incub
hour
plate
wash
three
time
detect
antibodi
murin
antibodi
ad
plate
incub
minut
plate
wash
three
time
streptavidinperoxidas
conjug
jackson
laboratori
west
grove
pa
ad
plate
incub
minut
plate
wash
three
time
tmb
chromogen
substrat
kirkegaard
perri
laboratori
gaithersburg
md
ad
plate
incub
room
temperatur
desir
extinct
reaction
termin
h
solut
plate
read
nm
autom
micropl
reader
biotek
instrument
inc
winooski
vt
standard
dilut
either
ng
pgml
ulwel
elisa
method
consist
detect
specif
chemokin
concentr
linear
fashion
greater
pgml
specif
sandwich
elisa
without
crossreact
panel
cytokin
includ
murin
je
human
rant
member
cxc
cc
chemokin
famili
whole
lung
singl
cell
suspens
made
harvest
lung
four
mice
per
group
use
method
previous
describ
singl
cell
suspens
cell
ml
stain
ab
tricolorconjug
bd
bioscienc
franklin
lake
nj
antimurin
caltag
laboratori
south
san
francisco
ca
fitcconjug
antimurin
macrophag
surfac
marker
seratec
raleigh
nc
rphycoerythrin
rpe
conjug
rat
antimurin
neutrophil
surfac
marker
rpeconjug
mous
antimurin
lymphocyt
surfac
marker
bd
bioscienc
dualcolorstain
cell
suspens
analyz
facscan
flow
cytomet
becton
dickinson
immunocytometri
system
san
jose
ca
use
cellquest
softwar
bd
immunocytometri
system
data
analyz
use
microsoft
excel
statist
packag
microsoft
corpor
usa
two
group
comparison
evalu
use
unpair
student
test
three
group
comparison
evalu
anova
test
post
hoc
analysi
ie
bonferroni
dunn
data
express
mean
sem
sinc
vitro
studi
human
epitheli
cell
demonstr
dsrna
induc
gener
chemokin
involv
leukocyt
recruit
perform
vivo
studi
use
murin
model
system
intratrach
dsrnainduc
inflamm
injuri
mimic
acut
viral
infect
thu
dissect
mechan
relat
process
put
receptor
dsrna
identifi
tolllik
receptor
thu
first
determin
whether
dsrna
treatment
associ
express
immunoloc
use
goat
antimurin
ab
show
markedli
increas
express
local
surfac
airway
epithelium
dsrnatreat
lung
compar
ssrnatreat
control
h
specif
demonstr
lack
stain
control
goat
iggstain
section
dsrna
ssrnatreat
group
fig
mice
treat
intratrach
dsrna
note
signific
intraparenchym
airway
leukocyt
infiltr
h
follow
treatment
compar
ssrnatreat
control
demonstr
histopatholog
fig
signific
differ
cellular
infiltr
note
among
histopatholog
group
earlier
timepoint
h
follow
dsrna
treatment
data
shown
fac
bal
analysi
h
follow
dsrna
treatment
specif
show
dsrna
induc
signific
neutrophil
recruit
compar
control
fig
determin
influx
neutrophil
lung
airway
parenchyma
result
lung
injuri
measur
two
marker
lung
injuri
quantifi
chang
lung
edema
lung
vascular
permeabl
result
show
signific
increas
wet
dri
ratio
dsrnatreat
lung
compar
control
h
follow
dsrna
treatment
fig
similarli
measur
lung
plasma
extravas
ratio
evan
blue
dye
also
show
signific
increas
microvascular
permeabl
dsrnatreat
lung
compar
control
fig
find
increas
lung
neutrophil
coincid
increas
lung
injuri
dsrnatreat
lung
next
attempt
determin
causal
relationship
induc
neutropenia
measur
chang
lung
neutrophil
influx
lung
injuri
mice
passiv
immun
specif
antimous
mab
correspond
control
h
well
h
follow
dsrna
treatment
lung
harvest
h
result
show
anim
pretreat
neutrophil
deplet
mab
signific
decreas
total
neutrophil
count
lung
tissu
airway
compar
control
reflect
fac
analysi
bal
fig
importantli
bal
sampl
anim
pretreat
antimous
mab
antibodi
show
specif
reduct
neutrophil
number
reduct
monocyt
number
data
shown
furthermor
neutrophil
deplet
result
decreas
lung
microvascular
permeabl
back
baselin
valu
fig
sinc
neutrophil
influx
shown
result
lung
injuri
dsrnatreat
lung
next
identifi
specif
factor
chemokin
respons
neutrophil
recruit
focus
elr
chemokin
known
neutrophil
chemoattract
properti
dsrna
treatment
result
signific
increas
lung
mrna
level
well
protein
level
whole
lung
homogen
bal
compar
control
fig
c
h
follow
dsrna
treatment
similarli
mrna
level
lung
protein
express
also
significantli
elev
increas
trend
note
bal
protein
dsrnatreat
lung
compar
control
fig
level
chemokin
ligand
earlier
timepoint
show
small
increas
twofold
induct
kc
earli
h
follow
dsrnaexposur
data
shown
maxim
increas
tenfold
fourfold
occur
h
follow
dsrnaexposur
share
cellular
receptor
murin
cxc
chemokin
ligand
find
increas
level
associ
dsrnainduc
neutrophil
sequestr
lung
injuri
led
us
evalu
express
mrna
lung
anim
lung
homogen
dsrnatreat
anim
significantli
increas
mrna
express
compar
control
fig
express
mrna
parallel
ligand
express
neutrophil
sequestr
lung
injuri
h
follow
dsrna
treatment
fig
better
understand
mechan
partli
respons
dsrnainduc
lung
neutrophilia
injuri
determin
whether
inhibit
ligand
interact
significantli
decreas
neutrophil
recruit
pathogenesi
dsrnainduc
lung
injuri
mice
passiv
immun
specif
neutral
antimurin
control
antibodi
h
well
h
follow
dsrna
dsrna
induc
express
airway
epitheli
cell
show
bal
neutrophil
count
anim
receiv
ab
significantli
reduc
compar
control
anim
receiv
normal
goat
serum
fig
furthermor
measur
lung
edema
lung
microvascular
permeabl
also
show
signific
decreas
wet
dri
evan
blue
extravas
mice
treat
compar
ngstreat
control
fig
final
histopatholog
comparison
lung
field
pretreat
mice
show
mark
reduct
leukocyt
infiltr
compar
ngspretreat
control
fig
respiratori
viral
infect
character
twocompon
immun
respons
compris
innat
compon
fulli
function
viral
entri
epithelium
adapt
compon
develop
respons
continu
presenc
viru
innat
acut
inflammatori
compon
associ
predomin
infiltr
neutrophil
mani
viral
infect
lung
selflimit
associ
lung
injuri
due
initi
event
may
critic
establish
proinflammatori
environ
underli
certain
chronic
respiratori
disord
asthma
copd
cystic
fibrosi
pulmonari
fibrosi
viral
pneumonia
bronchopulmonari
dysplasia
host
inflammatori
respons
viral
replic
lead
pulmonari
patholog
hallmark
leukocyt
infiltr
result
microvascular
leak
progress
lung
edema
clinic
sign
pneumonia
lung
injuri
persist
recur
multipl
subsequ
viral
infect
pulmonari
vascular
airway
remodel
may
occur
eventu
lead
develop
airway
hyperreact
andor
interstiti
fibrosi
viral
infect
mediat
dsrna
proinflammatori
molecul
gener
viral
replic
dsrna
bind
cell
surfac
receptor
activ
product
downstream
gene
product
cxc
chemokin
studi
hypothes
interact
elrposit
cxc
chemokin
express
dsrnainduc
lung
inflamm
critic
mediat
neutrophil
recruit
pivot
process
requir
dsrna
induc
lung
injuri
viral
infect
previou
studi
demonstr
mice
expos
live
viru
via
intranas
inocul
gener
system
acutephas
respons
maxim
pulmonari
chemokin
respons
one
week
includ
cc
cxc
chemokin
mous
straindepend
respons
balbc
greater
mice
similar
studi
use
intratrach
deliveri
live
viru
also
demonstr
mark
pulmonari
patholog
includ
mucou
cell
metaplasia
airway
epitheli
remodel
anoth
studi
focus
specif
effect
intratrach
dsrna
low
dose
found
similar
system
inflammatori
effect
specif
pulmonari
effect
dsrna
deliv
conjunct
final
recent
studi
examin
effect
inhibit
cc
chemokin
receptor
liveviru
exposur
mice
show
mortal
pneumoviru
infect
decreas
present
studi
extend
find
first
determin
effect
highdos
intratrach
dsrna
alon
neutrophil
recruit
lung
injuri
balbc
mice
subsequ
block
effect
via
inhibit
cxc
chemokin
receptor
determin
effect
dsrna
vivo
first
character
murin
model
perform
timecours
dsrna
observ
histopatholog
chang
h
follow
intratrach
dsrna
deliveri
use
maxim
dose
dsrna
mous
wt
initi
studi
lower
dose
show
minim
leukocyt
infiltr
furthermor
awar
one
public
describ
intratrach
dsrna
deliveri
show
effect
use
alon
low
concentr
ugg
histopatholog
analysi
demonstr
significantli
increas
leukocyt
infiltr
h
follow
intratrach
dsrna
compar
earlier
time
point
thu
chose
observ
basi
focu
upon
h
timepoint
studi
use
administr
dsrna
balbc
mice
vivo
also
shown
maxim
innat
immun
respons
start
h
follow
dsrna
exposur
character
h
follow
intratrach
dsrna
show
neutrophil
predomin
cell
type
associ
injuri
alveolarcapillari
membran
integr
shown
increas
lung
edema
microvascular
leak
character
histopatholog
damag
caus
intratrach
dsrna
focus
underli
mechan
respons
promot
inflamm
subsequ
lung
injuri
find
signific
increas
neutrophil
infiltr
follow
dsrna
treatment
consist
find
previou
studi
use
live
viru
also
result
earli
neutrophil
infiltr
order
determin
whether
neutrophil
influx
causal
link
lung
injuri
observ
system
perform
studi
use
monoclon
antibodi
antigen
surfac
mous
granulocyt
specif
deplet
neutrophil
result
show
decreas
number
lung
neutrophil
fac
analysi
bal
expect
reduct
monocyt
number
also
show
decreas
lung
microvascular
leak
therefor
decreas
lung
injuri
associ
decreas
neutrophil
recruit
howev
molecular
cellular
mechan
involv
recruit
neutrophil
remain
fulli
elucid
eleg
vitro
studi
demonstr
dsrna
induc
express
human
bronchial
epitheli
cell
furthermor
vivo
studi
use
live
viru
dsrna
increas
express
lung
figur
dsrna
increas
express
lung
quantit
realtim
pcr
determin
taqman
analysi
mrna
lung
h
follow
ssrna
dsrna
treatment
n
mice
per
group
p
also
demonstr
cxc
chemokin
gener
lung
inflamm
demonstr
lung
injuri
due
intratrach
dsrna
depend
neutrophil
infiltr
determin
express
significantli
greater
lung
dsrnatreat
mice
lung
ssrnatreat
control
furthermor
express
mrna
similarli
increas
parallel
product
ligand
neutrophil
sequestr
dsrnainduc
lung
inflamm
studi
inflammatori
diseas
ventilatorinduc
lung
injuri
pneumonia
hyperoxiainduc
lung
injuri
demonstr
import
express
role
neutrophil
recruit
pathogenesi
diseas
collect
studi
demonstr
augment
level
ligand
import
recruit
neutrophil
pathogenesi
inflammatori
diseas
suggest
interact
ligand
may
pivot
recruit
neutrophil
lung
dsrnainduc
lung
injuri
base
find
perform
proof
principl
studi
vivo
use
antibodymedi
neutral
strategi
evalu
direct
role
ligand
interact
pathogenesi
dsrnainduc
lung
injuri
abtreat
mice
demonstr
signific
reduct
specif
toneutrophil
infiltr
parallel
decreas
lung
injuri
suggest
leukocyt
recruit
redund
pathway
involv
recruit
find
similar
previou
neutral
studi
virusinfect
mice
show
function
antagon
chemokin
receptor
reduc
mortal
studi
first
demonstr
neutral
result
decreas
neutrophil
recruit
lung
injuri
induc
intratrach
dsrna
patternrecognit
cell
surfac
receptor
respons
specif
recogn
extracellular
dsrna
member
famili
tolllik
receptor
tlr
aid
host
combat
infect
microbi
pathogen
bind
specif
tolllik
receptor
trigger
downstream
gener
cytokin
costimulatori
molecul
innat
immun
attack
thu
play
import
role
host
defens
viral
infect
studi
show
dsrna
treatment
induc
express
cell
surfac
airway
compar
ssrnatreat
control
anim
upregul
dsrnaexpos
mous
airway
suggest
posit
feedback
system
epitheli
cell
expos
dsrna
increas
express
cell
surfac
similar
upregul
previous
describ
epitheli
cell
vitro
treat
respiratori
syncyti
viru
rsv
find
also
consist
vivo
studi
use
monoclon
antibodi
genet
knockout
mice
establish
role
dsrna
recognit
rais
interest
possibl
may
involv
signal
pathway
mediat
dsrna
induct
cxc
chemokin
conclus
demonstr
biolog
axi
signal
play
pivot
role
mediat
neutrophil
recruit
dsrnainduc
lung
injuri
mechan
may
critic
promot
lung
injuri
remodel
patient
eventu
develop
chronic
lung
diseas
asthma
copd
cystic
fibrosi
pulmonari
fibrosi
bronchopulmonari
dysplasia
find
current
studi
support
content
ligand
mediat
dsrnainduc
lung
injuri
may
therapeut
target
attenu
patholog
